Abstract
Adrenomedullin (AM) has various physiological actions on the cardiovascular system, including vasodilatation, diuresis, natriuresis, inhibition of aldosterone secretion, and increases of the cardiac output, all of which cause hypotension. Since AM plays a role in the pathophysiology of vascular diseases, genes controlling AM might be involved in the development and etiology of essential hypertension (EH). However, there have been few studies examining the relationship between the AM gene and hypertension. The aims of this study were to genotype some of the genetic markers for the human AM gene in Japanese subjects, and via a haplotype-based case-control study, assess the association between and the AM gene and EH or its risk factors, such as hyperlipidemia, renal damage, and proteinuria. We genotyped 205 EH patients and 210 age-matched normotensive (NT) individuals for two single nucleotide polymorphisms of rs4399321, rs7944706 and a microsatellite polymorphism located approximately 5,400 base pairs downstream of the 3′ end of the human AM gene. The overall distribution in each variant and haplotype did not significantly differ between the two groups. However, after dividing the groups into those subjects with and without proteinuria, the haplotype analysis revealed a positive association. In conclusion, a possible mutation linked to the haplotype may indicate a genetic predisposition for proteinuria in EH.
Similar content being viewed by others
Article PDF
References
Dominiczak AF, Negrin DC, Clark JS, Brosnan MJ, McBride MW, Alexander MY : Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000; 35: 164–172.
Colhoun H : Confirmation needed for genes for hypertension. Lancet 1999; 353: 1200–1201.
Kitamura K, Kangawa K, Kawamoto M, et al: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553–560.
Tanaka M, Kitamura K, Ishizaka Y, et al: Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects. Intern Med 1995; 34: 728–733.
Sugo S, Minamino N, Kangawa K, et al: Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160–1166.
Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K : Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 1997; 95: 1214–1221.
Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG : Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension. Hypertension 2000; 36: 588–593.
Zhang JJ, Yoshida H, Chao L, Chao J : Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive Dahl salt-sensitive rats. Hum Gene Ther 2000; 11: 1817–1827.
Caron KM, Smithies O : Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc Natl Acad Sci U S A 2001; 98: 615–619.
Ishimitsu T, Kojima M, Kangawa K, et al: Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994; 203: 631–639.
McLatchie LM, Fraser NJ, Main MJ, et al: RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393: 333–339.
Ishimitsu T, Hosoya K, Tsukada K, et al: Microsatellite DNA polymorphism of human adrenomedullin gene in normotensive subjects and patients with essential hypertension. Hypertension 2001; 38: 9–12.
Nakayama T, Soma M, Mizutani Y, et al: A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension. Hypertens Res 2002; 25: 395–401.
Hasimu B, Nakayama T, Mizutani Y, et al: A novel variable number of tandem repeat polymorphism of the renin gene and essential hypertension. Hypertens Res 2003; 26: 473–477.
Nakayama T, Soma M, Kanmatsuse K, Kokubun S : The microsatellite alleles on chromosome 1 associated with essential hypertension and blood pressure levels. J Hum Hypertens 2004; 18: 823–828.
Dempster AP, Laird NM, Rubin DB : Maximum likelihood from in complete data via the EM algorithm. J R Stat Soc [Ser B] 1977; 39: 1–38.
Hasimu B, Nakayama T, Mizutani Y, et al: Haplotype analysis of the human renin gene and essential hypertension. Hypertension 2003; 41: 308–312.
Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K, Esumi M : Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet 1997; 51: 26–30.
Excoffier L, Slatkin M : Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 921–927.
Nakayama T, Soma M, Haketa A, et al: Haplotype analysis of the prostacyclin synthase gene and essential hypertension. Hypertens Res 2003; 26: 553–557.
Fallin D, Cohen A, Essioux L, et al: Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 2001; 11: 143–151.
Shindo T, Kurihara H, Maemura K, et al: Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000; 101: 2309–2316.
Nishimatsu H, Hirata Y, Shindo T, et al: Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury: studies on transgenic/knockout mice of adrenomedullin gene. Circ Res 2002; 90: 657–663.
Shimosawa T, Shibagaki Y, Ishibashi K, et al: Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002; 105: 106–111.
Ando K, Fujita T : Lessons from the adrenomedullin knockout mouse. Regul Pept 2003; 112: 185–188.
Shindo T, Kurihara Y, Nishimatsu H, et al: Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2001; 104: 1964–1971.
Ishimitsu T, Tsukada K, Minami J, et al: Microsatellite DNA polymorphism of human adrenomedullin gene in type 2 diabetic patients with renal failure. Kidney Int 2003; 63: 2230–2235.
Nishikimi T, Mori Y, Kobayashi N, et al: Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension 2002; 39: 1077–1082.
Kubo A, Kurioka H, Minamino N, et al: Plasma and urinary levels of adrenomedullin in chronic glomerulonephritis patients with proteinuria. Nephron 1998; 80: 227–230.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kobayashi, Y., Nakayama, T., Sato, N. et al. Haplotype-Based Case-Control Study Revealing an Association between the Adrenomedullin Gene and Proteinuria in Subjects with Essential Hypertension. Hypertens Res 28, 229–236 (2005). https://doi.org/10.1291/hypres.28.229
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.28.229
Keywords
This article is cited by
-
Associations of the adrenomedullin gene polymorphism with prehypertension and hypertension in Lithuanian children and adolescents: a cross-sectional study
Scientific Reports (2019)
-
Association of adrenomedullin gene polymorphisms and blood pressure in a Chinese population
Hypertension Research (2013)
-
Haplotype-Based Case-Control Study on Human Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Gene and Essential Hypertension
American Journal of Hypertension (2010)
-
Purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene is associated with cerebral infarction in Japanese subjects
Hypertension Research (2009)
-
A haplotype in the human Sur2 gene is associated with essential hypertension
Journal of Human Hypertension (2006)
